Back
ProShares Ultra Real Estate Vs. ProShares Ultra Nasdaq Biotechnology Industry Stock Comparison
Buy
73
URE
ProShares Ultra Real Estate
Last Price:
76.20
Seasonality Move:
3.13%
Sell
49
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
66.09
Seasonality Move:
12.17%
Buy
73
ProShares Ultra Real Estate (URE)
is a Buy
Is ProShares Ultra Real Estate a Buy, Sell or Hold?
- The current ProShares Ultra Real Estate [URE] share price is $76.04. The Score for URE is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- URE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $65.66. The Score for BIB is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
URE Stock Price Chart
What is ProShares Ultra Real Estate's stock price today?
-
The ProShares Ultra Real Estate share price today is $76.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and URE is experiencing buying pressure, which is a positive indicator for future bullish movement.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $65.66
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIB is experiencing slight buying pressure.
URE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 60.36 | Buy |
| Chaikin Money Flow: | 3899 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (72.58 - 76.98) | Buy |
| Bollinger Bands (100): | (57.91 - 73.47) | Buy |
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 58.08 | Buy |
| Chaikin Money Flow: | 5146 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.88 - 66.3) | Buy |
| Bollinger Bands (100): | (59.2 - 66.5) | Buy |
URE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.59 | Buy |
| 20-day SMA: | 74.22 | Buy |
| 50-day SMA: | 72.44 | Buy |
| 200-day SMA: | 61.57 | Buy |
| 8-day EMA: | 73.63 | Buy |
| 20-day EMA: | 73.65 | Buy |
| 50-day EMA: | 71.67 | Buy |
| 200-day EMA: | 63.59 | Buy |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 62.85 | Buy |
| 20-day SMA: | 63.41 | Buy |
| 50-day SMA: | 64.39 | Buy |
| 200-day SMA: | 59.54 | Buy |
| 8-day EMA: | 63.65 | Buy |
| 20-day EMA: | 63.59 | Buy |
| 50-day EMA: | 63.77 | Buy |
| 200-day EMA: | 59.89 | Buy |
ProShares Ultra Real Estate Earnings Growth & URE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Real Estate Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||